Bone marrow-derived CD13+ cells sustain tumor progression: A potential non-malignant target for anticancer therapy

Eleonora Dondossola, Angelo Corti, Richard L. Sidman, Wadih Arap, Renata Pasqualini

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Non-malignant cells found within neoplastic lesions express alanyl (membrane) aminopeptidase (ANPEP, best known as CD13), and CD13-null mice exhibit limited tumor growth and angiogenesis. We have recently demonstrated that a subset of bone marrow-derived CD11b+CD13+ myeloid cells accumulate within neoplastic lesions in several murine models of transplantable cancer to promote angiogenesis. If these findings were confirmed in clinical settings, CD11b+CD13+ myeloid cells could become a non-malignant target for the development of novel anticancer regimens.

Original languageEnglish
Article numbere27716
JournalOncoImmunology
Volume3
Issue number1
DOIs
Publication statusPublished - 2014

Fingerprint

Myeloid Cells
Bone Marrow
CD13 Antigens
Neoplasms
Therapeutics
Growth

Keywords

  • Angiogenesis
  • Bone marrow-derived cells
  • CD13
  • Mouse models
  • Tumor

ASJC Scopus subject areas

  • Immunology and Allergy
  • Oncology
  • Immunology

Cite this

Bone marrow-derived CD13+ cells sustain tumor progression : A potential non-malignant target for anticancer therapy. / Dondossola, Eleonora; Corti, Angelo; Sidman, Richard L.; Arap, Wadih; Pasqualini, Renata.

In: OncoImmunology, Vol. 3, No. 1, e27716, 2014.

Research output: Contribution to journalArticle

Dondossola, Eleonora ; Corti, Angelo ; Sidman, Richard L. ; Arap, Wadih ; Pasqualini, Renata. / Bone marrow-derived CD13+ cells sustain tumor progression : A potential non-malignant target for anticancer therapy. In: OncoImmunology. 2014 ; Vol. 3, No. 1.
@article{039a04fa61be4d92858bccfa67f40e66,
title = "Bone marrow-derived CD13+ cells sustain tumor progression: A potential non-malignant target for anticancer therapy",
abstract = "Non-malignant cells found within neoplastic lesions express alanyl (membrane) aminopeptidase (ANPEP, best known as CD13), and CD13-null mice exhibit limited tumor growth and angiogenesis. We have recently demonstrated that a subset of bone marrow-derived CD11b+CD13+ myeloid cells accumulate within neoplastic lesions in several murine models of transplantable cancer to promote angiogenesis. If these findings were confirmed in clinical settings, CD11b+CD13+ myeloid cells could become a non-malignant target for the development of novel anticancer regimens.",
keywords = "Angiogenesis, Bone marrow-derived cells, CD13, Mouse models, Tumor",
author = "Eleonora Dondossola and Angelo Corti and Sidman, {Richard L.} and Wadih Arap and Renata Pasqualini",
year = "2014",
doi = "10.4161/onci.27716",
language = "English",
volume = "3",
journal = "OncoImmunology",
issn = "2162-4011",
publisher = "Taylor and Francis Inc.",
number = "1",

}

TY - JOUR

T1 - Bone marrow-derived CD13+ cells sustain tumor progression

T2 - A potential non-malignant target for anticancer therapy

AU - Dondossola, Eleonora

AU - Corti, Angelo

AU - Sidman, Richard L.

AU - Arap, Wadih

AU - Pasqualini, Renata

PY - 2014

Y1 - 2014

N2 - Non-malignant cells found within neoplastic lesions express alanyl (membrane) aminopeptidase (ANPEP, best known as CD13), and CD13-null mice exhibit limited tumor growth and angiogenesis. We have recently demonstrated that a subset of bone marrow-derived CD11b+CD13+ myeloid cells accumulate within neoplastic lesions in several murine models of transplantable cancer to promote angiogenesis. If these findings were confirmed in clinical settings, CD11b+CD13+ myeloid cells could become a non-malignant target for the development of novel anticancer regimens.

AB - Non-malignant cells found within neoplastic lesions express alanyl (membrane) aminopeptidase (ANPEP, best known as CD13), and CD13-null mice exhibit limited tumor growth and angiogenesis. We have recently demonstrated that a subset of bone marrow-derived CD11b+CD13+ myeloid cells accumulate within neoplastic lesions in several murine models of transplantable cancer to promote angiogenesis. If these findings were confirmed in clinical settings, CD11b+CD13+ myeloid cells could become a non-malignant target for the development of novel anticancer regimens.

KW - Angiogenesis

KW - Bone marrow-derived cells

KW - CD13

KW - Mouse models

KW - Tumor

UR - http://www.scopus.com/inward/record.url?scp=84899128535&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899128535&partnerID=8YFLogxK

U2 - 10.4161/onci.27716

DO - 10.4161/onci.27716

M3 - Article

AN - SCOPUS:84899128535

VL - 3

JO - OncoImmunology

JF - OncoImmunology

SN - 2162-4011

IS - 1

M1 - e27716

ER -